Scientists probe why some breast cancers resist hormone drugs
NCT ID NCT06127979
Summary
This study aims to understand if breast cancers in women with BRCA2 gene mutations respond differently to hormone therapy before surgery compared to cancers in women without these mutations. Researchers will measure a specific protein (Ki67) in tumor samples before and after at least two weeks of treatment. The goal is to gather knowledge that may help tailor future treatments, but this study itself does not test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.